Stocks analysis

Analysis for CSGP

$32.00 +1.89 (+6.28%)
  • 📈 Growth — 22/30
  • 💰 Profitability — 16/20
  • 🏦 Financial Health — 19/20
  • 💵 Valuation — 14/20
  • ⚠️ Risk — 7/10
Overall Score: 74/100

Summary:


📈 Growth & Financial Trajectory

Over the 8 quarters, Revenues rose from about $656.4M to $897.0M, about +37%. Net income fluctuated from $6.7M in 2024 Q1 to $3.0M in 2026 Q1, after peaking at $59.8M in 2024 Q4, signaling strong top line growth but earnings volatility. The trend shows momentum into late 2024, a dip in 2025 Q1, with a modest recovery by early 2026.

💰 Margins & Cash Flow

Gross margin has been robust, around the mid-80s, roughly 78-86% across quarters. Operating leverage is mixed as high operating expenses compress margins in several quarters, but profitability returns in some periods (Q3-Q4 2024 and 2026 Q1). Net cash flow from operating activities was positive in multiple quarters (e.g., 2024 Q2 $100.3M, 2025 Q1 $146.5M), while investing and financing activities often consumed cash, culminating in a 2026 Q1 net cash flow of -$417M.

🛡️ Balance Sheet & Liquidity

Assets of about $10.16B vs Liabilities of $2.21B, yielding Equity near $7.95B. Long-term Debt is $1.0B, indicating solid balance-sheet resilience and ample cushion for volatility.

⚠️ Key Drivers & Risks

  • Drivers: Recurring license/subscription revenue; high-margin data products.
  • Risks: Cash-flow volatility; reliance on external financing and macro real estate cycles.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $11.87B
P/E Ratio 161.28
Forward P/E 18.62
P/S Ratio 3.34
P/B Ratio 1.46
EV / EBITDA 51.75
Profitability & Returns
Gross Margin 78.68%
Operating Margin 2.17%
Net Margin 2.07%
ROE 0.90%
ROIC 0.80%
Financial Health & Liquidity
Current Ratio 2.21
Quick Ratio 2.06
Financial Scale & Cash Flow
Revenue $3.56B
Net Income $0.07B
FCF Yield 2.11%
Free Cash Flow $0.25B
Total Debt To Equity 0.13